Characteristics of West Nile encephalitis in the Autonomous Province of Vojvodina in the period 2021 to 2022
Introduction. Neuroinvasive the West Nile virus disease develops in less than 1% of infected individuals, with a mortality rate of approximately 9%. This scientific research aimed to analyze the epidemiological, clinical, and laboratory characteristics, the presence of comorbidities, and the treatme...
Saved in:
Published in | Medicinski pregled Vol. 77; no. 1-2; pp. 31 - 35 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
2024
|
Online Access | Get full text |
ISSN | 0025-8105 1820-7383 |
DOI | 10.2298/MPNS2402031P |
Cover
Abstract | Introduction. Neuroinvasive the West Nile virus disease develops in less than
1% of infected individuals, with a mortality rate of approximately 9%. This
scientific research aimed to analyze the epidemiological, clinical, and
laboratory characteristics, the presence of comorbidities, and the treatment
outcome of West Nile encephalitis in 2021 and 2022. Material and Methods.
The retrospective study includes 33 patients treated at the Infectious
Diseases Clinic of the University Clinical Center of Vojvodina from January
1, 2021 to December 31, 2022. The diagnosis was confirmed by serological
tests and/or real-time reverse transcriptase polymerase chain reaction of
cerebrospinal fluid. Results. The study demonstrated a statistically
significant predominance of males (57.6%) over females (42.4%) (?2=4.5;
p=0.03).Individuals over the age of 65 accounted for 51.52% of cases, with
the remaining 48.48% being within the working-age population. The highest
concentration of cases was observed in the Novi Sad (24.2%). Upon admission,
elevated body temperature was prevalent 97% of patients (?2 = 8.8; p =
0.03), followed by weakness and malaise in 75.8%, and altered consciousness
in 66.7%. Meningeal signs were present in only 48% of patients. Infection
was confirmed in all patients through serological analysis of cerebrospinal
fluid. A fatal outcome was observed in 31.3% of cases. Conclusion. The
results of the research indicate that serological analysis is the most
reliable method for diagnosing the neuroinvasive form of infection. |
---|---|
AbstractList | Introduction. Neuroinvasive the West Nile virus disease develops in less than
1% of infected individuals, with a mortality rate of approximately 9%. This
scientific research aimed to analyze the epidemiological, clinical, and
laboratory characteristics, the presence of comorbidities, and the treatment
outcome of West Nile encephalitis in 2021 and 2022. Material and Methods.
The retrospective study includes 33 patients treated at the Infectious
Diseases Clinic of the University Clinical Center of Vojvodina from January
1, 2021 to December 31, 2022. The diagnosis was confirmed by serological
tests and/or real-time reverse transcriptase polymerase chain reaction of
cerebrospinal fluid. Results. The study demonstrated a statistically
significant predominance of males (57.6%) over females (42.4%) (?2=4.5;
p=0.03).Individuals over the age of 65 accounted for 51.52% of cases, with
the remaining 48.48% being within the working-age population. The highest
concentration of cases was observed in the Novi Sad (24.2%). Upon admission,
elevated body temperature was prevalent 97% of patients (?2 = 8.8; p =
0.03), followed by weakness and malaise in 75.8%, and altered consciousness
in 66.7%. Meningeal signs were present in only 48% of patients. Infection
was confirmed in all patients through serological analysis of cerebrospinal
fluid. A fatal outcome was observed in 31.3% of cases. Conclusion. The
results of the research indicate that serological analysis is the most
reliable method for diagnosing the neuroinvasive form of infection. |
Author | Prastalo, Danijela Djukic, Tijana Sevic, Sinisa Boljanovic, Vanja Petric, Vedrana Bulovic, Aleksandra |
Author_xml | – sequence: 1 givenname: Danijela orcidid: 0009-0004-0584-7769 surname: Prastalo fullname: Prastalo, Danijela organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad – sequence: 2 givenname: Vanja orcidid: 0009-0001-7287-532X surname: Boljanovic fullname: Boljanovic, Vanja organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad – sequence: 3 givenname: Vedrana orcidid: 0000-0001-5948-4140 surname: Petric fullname: Petric, Vedrana organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad + University of Novi Sad, Faculty of Medicine, Novi Sad – sequence: 4 givenname: Tijana orcidid: 0009-0005-7252-6241 surname: Djukic fullname: Djukic, Tijana organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad – sequence: 5 givenname: Aleksandra orcidid: 0009-0004-3636-5949 surname: Bulovic fullname: Bulovic, Aleksandra organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad – sequence: 6 givenname: Sinisa orcidid: 0009-0009-3267-1195 surname: Sevic fullname: Sevic, Sinisa organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad + University of Novi Sad, Faculty of Medicine, Novi Sad |
BookMark | eNpNkM1KAzEUhYNUsK3ufIA8gKP3JvOTWZaiVqi1YNHlkEkyTMp0MiRpwbe3gwquzuJ851ucGZn0rjeE3CLcM1aKh9ft5p2lwIDj9oJMUTBICi74hEwBWJYIhOyKzELYA-SYg5iSbtlKL1U03oZoVaCuoZ8mRLqxnaGmV2ZoZWejDdT2NLaGLo7R9e7gjoFuvTvZMzKOPtz-5LTt5R83nJVOUwYMaXRjsmty2cgumJvfnJPd0-NuuUrWb88vy8U6UUU2JGVdgzYSS1MXOULKU2QsyxVyQM6x0ZlSQmtVZ6xUhTy3vM4bUae8AcV0yufk7kervAvBm6YavD1I_1UhVONR1f-j-Dfr_VzN |
Cites_doi | 10.1007/978-3-7091-0572-6_4 10.1371/journal.pntd.0002184 10.1007/s00406-011-0222-6 10.1093/cid/ciaa749 10.1089/088282403322396082 10.1016/j.femsle.2004.01.035 10.1016/S0140-6736(98)03538-7 10.1016/B978-0-7020-3468-8.50052-3 10.1146/annurev.med.57.121304.131418 10.3201/eid0903.020628 10.3201/eid1108.050289b 10.3201/eid1207.060164 10.1089/vbz.2010.0206 10.2298/VSP140718115S 10.2807/1560-7917.ES.2021.26.19.2001095 10.4269/ajtmh.2005.72.768 10.1038/nm1140 10.3201/eid1905.121418 10.1089/153036604773083004 10.3201/eid1812.111208 10.1111/1469-0691.12211 10.2298/MPNS1604093H 10.1201/9780429289200-3 10.2807/1560-7917.ES2013.18.43.20613 10.4103/ijmr.IJMR_642_19 10.15585/mmwr.mm7118a3 10.1001/jama.290.4.511 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.2298/MPNS2402031P |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1820-7383 |
EndPage | 35 |
ExternalDocumentID | 10_2298_MPNS2402031P |
GroupedDBID | 2WC 53G 53S 5GY AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION CS3 DIK DU5 EBD EMOBN EN8 EOJEC ESX F5P IAO IHR INR KQ8 MK0 OBODZ OK1 PV9 RNS RZL SV3 TUS ~8M |
ID | FETCH-LOGICAL-c75p-9bb0dea19eb761043412256c1301331fd5cc8ddcb529c7a4123b6f8b43f0c2d43 |
ISSN | 0025-8105 |
IngestDate | Tue Jul 01 02:45:35 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c75p-9bb0dea19eb761043412256c1301331fd5cc8ddcb529c7a4123b6f8b43f0c2d43 |
ORCID | 0000-0001-5948-4140 0009-0001-7287-532X 0009-0004-0584-7769 0009-0005-7252-6241 0009-0009-3267-1195 0009-0004-3636-5949 |
OpenAccessLink | https://doi.org/10.2298/mpns2402031p |
PageCount | 5 |
ParticipantIDs | crossref_primary_10_2298_MPNS2402031P |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-00-00 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – year: 2024 text: 2024-00-00 |
PublicationDecade | 2020 |
PublicationTitle | Medicinski pregled |
PublicationYear | 2024 |
References | ref13 ref12 ref15 ref14 ref11 ref10 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref1 – ident: ref4 doi: 10.1007/978-3-7091-0572-6_4 – ident: ref14 doi: 10.1371/journal.pntd.0002184 – ident: ref25 doi: 10.1007/s00406-011-0222-6 – ident: ref24 doi: 10.1093/cid/ciaa749 – ident: ref6 doi: 10.1089/088282403322396082 – ident: ref8 doi: 10.1016/j.femsle.2004.01.035 – ident: ref19 doi: 10.1016/S0140-6736(98)03538-7 – ident: ref2 doi: 10.1016/B978-0-7020-3468-8.50052-3 – ident: ref3 doi: 10.1146/annurev.med.57.121304.131418 – ident: ref5 doi: 10.3201/eid0903.020628 – ident: ref11 doi: 10.3201/eid1108.050289b – ident: ref16 doi: 10.3201/eid1207.060164 – ident: ref21 doi: 10.1089/vbz.2010.0206 – ident: ref18 doi: 10.2298/VSP140718115S – ident: ref23 doi: 10.2807/1560-7917.ES.2021.26.19.2001095 – ident: ref10 doi: 10.4269/ajtmh.2005.72.768 – ident: ref7 doi: 10.1038/nm1140 – ident: ref20 doi: 10.3201/eid1905.121418 – ident: ref15 doi: 10.1089/153036604773083004 – ident: ref27 doi: 10.3201/eid1812.111208 – ident: ref13 doi: 10.1111/1469-0691.12211 – ident: ref17 doi: 10.2298/MPNS1604093H – ident: ref12 doi: 10.1201/9780429289200-3 – ident: ref26 doi: 10.2807/1560-7917.ES2013.18.43.20613 – ident: ref28 doi: 10.4103/ijmr.IJMR_642_19 – ident: ref22 doi: 10.15585/mmwr.mm7118a3 – ident: ref9 doi: 10.1001/jama.290.4.511 |
SSID | ssj0061608 |
Score | 2.2774 |
Snippet | Introduction. Neuroinvasive the West Nile virus disease develops in less than
1% of infected individuals, with a mortality rate of approximately 9%. This... |
SourceID | crossref |
SourceType | Index Database |
StartPage | 31 |
Title | Characteristics of West Nile encephalitis in the Autonomous Province of Vojvodina in the period 2021 to 2022 |
Volume | 77 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVEJcEE8BBbQHOFUG7_qx9jFtqSqkVJEIVW_RvgJ2LTtqHA79F_xjZrJex0Q9FC52tA9byXyZ-fbx7RDywWibScHyINYJDFDizAZKCx7oLJSAIIigIQqcpxfp-ff461VyNRr9Huxa2rTqk769U1fyP1aFMrArqmT_wbL9Q6EAPoN94QoWhuu9bHyyd9oyED_MFAPmrewR_mVXP5FmF2u_m3GyaVHEgNteZ9u5BL2dMrhsyl8NBDHp2-Hxx4054hCakZzCnQ9Z7NQtyK-vCzxj4EfVCaTQw97INc4HefV6aavdiL-pSlnDW7dJ1S9lXcqdY8ZEAdtiayB69hWn5ebaVcyL0pd3kxROFd3LBZIgY6FburbOywLtCETkMth4N9xlcyn-0kQ6r9rFCRef3ekm-56f8xzVDNPZxTdcLwJXNdtFOL-qvxf4-u2IMBDC_oth7wfkgAvB4jE5mByfHp_58J6yNMx8HmD8Xk5Ngf0_D_sPeM6AsMyfkMfdSINOHGyekpGtn5GHnensc1LtoYc2S4rooYgeOkQPLWoKqKA79FCPHuzUo8e3c-ihiB7aNnjnL8j87Mv85Dzocm8EWiSrIFcqNFay3CoBBDsGrgOOP9XAeFgUsaVJtM6M0SrhuRYSaiOVLjMVR8tQcxNHL8m4bmr7ilALBFaxxHIr8Ckqi1hijNIJF3FqmHpNPvofarFyJ6ws7jLIm3u2OySPEIFumuwtGbc3G_sOiGOr3nem_AP4z22U |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristics+of+West+Nile+encephalitis+in+the+Autonomous+Province+of+Vojvodina+in+the+period+2021+to+2022&rft.jtitle=Medicinski+pregled&rft.au=Prastalo%2C+Danijela&rft.au=Boljanovic%2C+Vanja&rft.au=Petric%2C+Vedrana&rft.au=Djukic%2C+Tijana&rft.date=2024&rft.issn=0025-8105&rft.eissn=1820-7383&rft.volume=77&rft.issue=1-2&rft.spage=31&rft.epage=35&rft_id=info:doi/10.2298%2FMPNS2402031P&rft.externalDBID=n%2Fa&rft.externalDocID=10_2298_MPNS2402031P |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-8105&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-8105&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-8105&client=summon |